ISSN: 1932-9520

Journal Guideline

Current Cardiovascular Risk Reports Q3 Unclaimed

Current Medicine Group United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Cardiovascular Risk Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging concepts related to cardiovascular risk. It has an SJR impact factor of 0,491.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q3) Pharmacology (medical) (Q3) Pharmacology (medical) (Q3)

Price

2690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,491

SJR Impact factor

34

H Index

21

Total Docs (Last Year)

72

Total Docs (3 years)

1537

Total Refs

119

Total Cites (3 years)

72

Citable Docs (3 years)

1.94

Cites/Doc (2 years)

73.19

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Toxicology Q3
Journal of Antibiotics Q3
Human Psychopharmacology Q3
Current molecular pharmacology Q3
Journal of Physiology and Pharmacology Q3

Compare this journals

Aims and Scope

Best articles by citations

Race, ethnicity, biology, and medical research: A modest proposal

The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe

Diabetes and Cardiovascular Disease Risk Factors as Influenced by Race and Ethnic Background

State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

Is vitamin D an overlooked contributor to excess cardiovascular disease in blacks?

Clinical Implications of Lipid Genetics for Cardiovascular Disease

Should we use ambulatory blood pressure monitoring to guide therapy?

Cardiovascular disease in South Asians: A burgeoning epidemic

Cardiovascular Disease Risk Among Light and Nondaily Smokers

Secondary Prevention of Heart Disease in Women: Gaps in Care/Gaps in Knowledge - Where Do We Need to Focus Our Attention

Medical Management Before Bariatric Surgery

SHOW MORE ARTICLES

Hypertension in women

Arterial stiffness and systolic hypertension: Determinants, assessment, and clinical consequences

Weight Loss Drugs and Cardiovascular Risks

The genetic basis of cardiomyopathy

The neurobiology and treatment of tobacco dependence

HIV and Cardiovascular Disease: The Impact of Cigarette Smoking

Screening for Familial Hypercholesterolaemia: Universal or Cascade? A Critique of Current FH Recognition Strategies

beta-Blockers: No longer an option for uncomplicated hypertension

Measurements of arterial stiffness: Are they ready for clinical use?

Diabetes in the elderly

Environmental, societal, and genetic contributions to the epidemic of hypertension in African Americans

Single and dual blockade of the renin-angiotensin system in high-risk patients without heart failure: Lessons from ONTARGET